ELAPEGADEMASE-LVLR

ELAPEGADEMASE-LVLR was reported 299 times

ELAPEGADEMASE-LVLR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OMENN SYNDROME 1 0.3333
1 ADENOSINE DEAMINASE DECREASED 1 0.1429
2 FONTANELLE DEPRESSED 1 0.0370
3 INFANT IRRITABILITY 2 0.0204
4 SYSTEMIC BACTERIAL INFECTION 1 0.0133
5 MALPOSITIONED TEETH 1 0.0087
6 BREAST ULCERATION 1 0.0072
7 BONE MARROW TRANSPLANT 13 0.0068
8 TEETHING 2 0.0067
9 COMBINED IMMUNODEFICIENCY 1 0.0062
10 VIRAL SINUSITIS 1 0.0047
11 NAIL PIGMENTATION 1 0.0041
12 GROWTH DISORDER 1 0.0037
13 CEREBRAL FUNGAL INFECTION 1 0.0035
14 ADNEXA UTERI MASS 1 0.0035
15 CENTRAL HYPOTHYROIDISM 1 0.0030
16 METAPNEUMOVIRUS INFECTION 2 0.0026
17 VOCAL CORD DYSFUNCTION 1 0.0020
18 MORNING SICKNESS 1 0.0018
19 NOROVIRUS INFECTION 2 0.0014
20 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
21 SCROTAL SWELLING 1 0.0011
22 ANIMAL SCRATCH 1 0.0010
23 BREAST DISCOMFORT 1 0.0010
24 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
25 OTITIS EXTERNA 1 0.0008
26 STEM CELL TRANSPLANT 2 0.0008
27 PHARYNGEAL ULCERATION 1 0.0008
28 POST HERPETIC NEURALGIA 1 0.0007
29 SMALL CELL LUNG CANCER 1 0.0007
30 ONYCHOLYSIS 1 0.0006
31 METABOLIC SYNDROME 1 0.0006
32 SEBORRHOEIC DERMATITIS 1 0.0006
33 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
34 TETANY 1 0.0005
35 THROMBOCYTOSIS 2 0.0005
36 NASAL OBSTRUCTION 1 0.0005
37 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
38 INSULIN RESISTANCE 1 0.0005
39 MIDDLE EAR EFFUSION 1 0.0005
40 GASTROINTESTINAL ULCER 1 0.0005
41 BRONCHIECTASIS 3 0.0004
42 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
43 VARICELLA 1 0.0004
44 BRAIN ABSCESS 1 0.0004
45 NOCARDIOSIS 1 0.0004
46 SKIN DISCOMFORT 1 0.0004
47 ELECTRIC SHOCK SENSATION 1 0.0004
48 SKIN HYPERTROPHY 1 0.0004
49 GROWTH RETARDATION 1 0.0003
50 ATYPICAL PNEUMONIA 1 0.0003
51 B-CELL LYMPHOMA 1 0.0003
52 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
53 GRANULOMA 1 0.0003
54 DEPRESSIVE SYMPTOM 1 0.0003
55 GASTROENTERITIS VIRAL 5 0.0003
56 RHINOVIRUS INFECTION 1 0.0003
57 PNEUMONIA FUNGAL 1 0.0003
58 OESOPHAGEAL CANDIDIASIS 1 0.0003
59 POOR PERIPHERAL CIRCULATION 1 0.0002
60 ABDOMINAL ABSCESS 1 0.0002
61 VIRAL INFECTION 7 0.0002
62 BREATH SOUNDS ABNORMAL 1 0.0002
63 ANEURYSM 1 0.0002
64 NASOPHARYNGITIS 37 0.0002
65 COMPRESSION FRACTURE 1 0.0002
66 STREPTOCOCCAL INFECTION 1 0.0002
67 EYE INFECTION 2 0.0002
68 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
69 PIGMENTATION DISORDER 1 0.0002
70 RHINORRHOEA 10 0.0002
71 PRODUCT PREPARATION ISSUE 1 0.0002
72 ASPERGILLUS INFECTION 1 0.0002
73 CORONAVIRUS INFECTION 1 0.0002
74 ECCHYMOSIS 1 0.0001
75 SEASONAL ALLERGY 2 0.0001
76 ORAL DISORDER 1 0.0001
77 SENSITIVE SKIN 1 0.0001
78 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
79 PULMONARY HAEMORRHAGE 1 0.0001
80 SINUSITIS 13 0.0001
81 COVID-19 22 0.0001
82 PRODUCT DOSE OMISSION 8 0.0001
83 CANDIDA INFECTION 2 0.0001
84 PSEUDOMONAS INFECTION 1 0.0001
85 HYSTERECTOMY 1 0.0001
86 RESPIRATORY TRACT INFECTION 3 0.0001
87 LUNG INFILTRATION 1 0.0001
88 PURPURA 1 0.0001
89 BRAIN NEOPLASM 1 0.0001
90 HOSPICE CARE 1 0.0001
91 EYE DISCHARGE 1 0.0001
92 FULL BLOOD COUNT ABNORMAL 1 0.0001
93 SUDDEN DEATH 1 0.0001
94 SNEEZING 2 0.0001
95 MICTURITION URGENCY 1 0.0001
96 THYROID CANCER 1 0.0001
97 COUGH 23 0.0001
98 PHARYNGITIS 1 0.0001
99 MUSCLE ATROPHY 1 0.0001
100 INFLAMMATION 4 0.0001
101 PLATELET COUNT INCREASED 1 0.0001
102 IMMUNE SYSTEM DISORDER 1 0.0001
103 EAR INFECTION 2 0.0001
104 BLOOD BILIRUBIN INCREASED 2 0.0001
105 HYPERSOMNIA 2 0.0001
106 HERPES ZOSTER 4 0.0001
107 NASAL CONGESTION 4 0.0001
108 ILL-DEFINED DISORDER 4 0.0001
109 INJECTION SITE RASH 2 0.0001
110 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
111 LYMPHOMA 1 0.0001
112 MUSCULOSKELETAL CHEST PAIN 1 0.0001
113 PNEUMOTHORAX 1 0.0001
114 INFLUENZA 7 0.0001
115 ABSCESS 1 0.0001
116 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
117 COAGULOPATHY 1 0.0001
118 SKIN DISORDER 2 0.0001
119 SCAR 1 0.0001
120 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
121 LYMPHOCYTE COUNT DECREASED 1 0.0001
122 GALLBLADDER DISORDER 1 0.0001
123 OSTEOMYELITIS 1 0.0001
124 CRYING 2 0.0001
125 DYSURIA 2 0.0001
126 INJECTION SITE MASS 2 0.0001
127 OROPHARYNGEAL PAIN 5 0.0001
128 CONJUNCTIVITIS 1 0.0001
129 MIDDLE INSOMNIA 1 0.0001
130 HYPOCALCAEMIA 1 0.0001
131 LETHARGY 3 0.0001
132 LOWER LIMB FRACTURE 1 0.0001
133 KIDNEY INFECTION 1 0.0001
134 PREGNANCY 1 0.0000
135 BODY TEMPERATURE INCREASED 1 0.0000
136 DERMATITIS 1 0.0000
137 EATING DISORDER 1 0.0000
138 IRRITABLE BOWEL SYNDROME 1 0.0000
139 APPLICATION SITE PAIN 1 0.0000
140 RASH PAPULAR 1 0.0000
141 WEIGHT DECREASED 12 0.0000
142 PRODUCTIVE COUGH 2 0.0000
143 LOCALISED INFECTION 1 0.0000
144 NEURALGIA 1 0.0000
145 LUNG DISORDER 2 0.0000
146 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
147 PNEUMONIA 13 0.0000
148 HYPOPHAGIA 1 0.0000
149 ILLNESS 4 0.0000
150 UNRESPONSIVE TO STIMULI 1 0.0000
151 JAUNDICE 1 0.0000
152 HAEMOPTYSIS 1 0.0000
153 WEIGHT INCREASED 8 0.0000
154 PAIN IN JAW 1 0.0000
155 INFECTION 5 0.0000
156 LABORATORY TEST ABNORMAL 1 0.0000
157 GASTROINTESTINAL DISORDER 3 0.0000
158 RESPIRATORY DISORDER 1 0.0000
159 STOMATITIS 2 0.0000
160 EPILEPSY 1 0.0000
161 INJECTION SITE PAIN 10 0.0000
162 NERVOUS SYSTEM DISORDER 1 0.0000
163 PYREXIA 11 0.0000
164 HYPOTHYROIDISM 1 0.0000
165 EYE DISORDER 1 0.0000
166 DECREASED APPETITE 7 0.0000
167 EXPIRED PRODUCT ADMINISTERED 1 0.0000
168 FUNGAL INFECTION 1 0.0000
169 URINARY RETENTION 1 0.0000
170 INJECTION SITE REACTION 2 0.0000
171 LYMPHADENOPATHY 1 0.0000
172 SKIN BURNING SENSATION 2 0.0000
173 THROMBOCYTOPENIA 3 0.0000
174 ABNORMAL BEHAVIOUR 1 0.0000
175 NEUTROPHIL COUNT DECREASED 1 0.0000
176 INFLUENZA LIKE ILLNESS 2 0.0000
177 RECTAL HAEMORRHAGE 1 0.0000
178 LIVER DISORDER 1 0.0000
179 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
180 NEPHROLITHIASIS 1 0.0000
181 HYPOKALAEMIA 1 0.0000
182 COGNITIVE DISORDER 1 0.0000
183 NEUROPATHY PERIPHERAL 2 0.0000
184 DISEASE RECURRENCE 1 0.0000
185 RASH ERYTHEMATOUS 1 0.0000
186 MUSCULOSKELETAL PAIN 1 0.0000
187 DEPRESSED MOOD 1 0.0000
188 PLATELET COUNT DECREASED 2 0.0000
189 RASH PRURITIC 1 0.0000
190 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
191 RASH 8 0.0000
192 TREATMENT NONCOMPLIANCE 1 0.0000
193 HAEMATOCHEZIA 1 0.0000
194 MEDICATION ERROR 1 0.0000
195 BLISTER 1 0.0000
196 URINARY TRACT INFECTION 3 0.0000
197 PALPITATIONS 2 0.0000
198 SURGERY 1 0.0000
199 IRRITABILITY 1 0.0000
200 EXPOSURE DURING PREGNANCY 1 0.0000
201 ANAEMIA 3 0.0000
202 DEEP VEIN THROMBOSIS 1 0.0000
203 BLOOD CREATININE INCREASED 1 0.0000
204 DRY SKIN 2 0.0000
205 HEPATIC ENZYME INCREASED 1 0.0000
206 EPISTAXIS 1 0.0000
207 HOT FLUSH 1 0.0000
208 CONDITION AGGRAVATED 4 0.0000
209 DIABETES MELLITUS 1 0.0000
210 INJECTION SITE SWELLING 1 0.0000
211 INJECTION SITE BRUISING 1 0.0000
212 INJECTION SITE HAEMORRHAGE 1 0.0000
213 DIARRHOEA 8 0.0000
214 URTICARIA 2 0.0000
215 MYALGIA 2 0.0000
216 OFF LABEL USE 10 0.0000
217 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
218 ADVERSE EVENT 1 0.0000
219 CHEST PAIN 2 0.0000
220 CARDIAC DISORDER 1 0.0000
221 ANXIETY 3 0.0000
222 MIGRAINE 1 0.0000
223 CONTUSION 1 0.0000
224 DRUG INTOLERANCE 1 0.0000
225 PRODUCT DOSE OMISSION ISSUE 3 0.0000
226 ALOPECIA 2 0.0000
227 HAEMOGLOBIN DECREASED 1 0.0000
228 HEADACHE 6 0.0000
229 MUSCULAR WEAKNESS 1 0.0000
230 DEPRESSION 2 0.0000
231 SEIZURE 1 0.0000
232 BACK PAIN 2 0.0000
233 CHILLS 1 0.0000
234 VOMITING 4 0.0000
235 PSORIASIS 1 0.0000
236 DEHYDRATION 1 0.0000
237 NEUTROPENIA 1 0.0000
238 MEMORY IMPAIRMENT 1 0.0000
239 ARTHRALGIA 3 0.0000
240 DYSPNOEA 4 0.0000
241 PERIPHERAL SWELLING 1 0.0000
242 ABDOMINAL DISCOMFORT 1 0.0000
243 CEREBROVASCULAR ACCIDENT 1 0.0000
244 DEATH 5 0.0000
245 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
246 HYPERSENSITIVITY 1 0.0000
247 ASTHENIA 2 0.0000
248 PRURITUS 2 0.0000
249 SOMNOLENCE 1 0.0000
250 ERYTHEMA 1 0.0000
251 ABDOMINAL PAIN UPPER 1 0.0000
252 OVERDOSE 1 0.0000
253 CONSTIPATION 1 0.0000
254 INCORRECT DOSE ADMINISTERED 1 0.0000
255 ABDOMINAL PAIN 1 0.0000
256 FATIGUE 3 0.0000
257 INSOMNIA 1 0.0000
258 PAIN IN EXTREMITY 1 0.0000
259 PAIN 2 0.0000
260 FALL 1 0.0000
261 NAUSEA 2 0.0000
262 MALAISE 1 0.0000
263 DRUG INEFFECTIVE 1 0.0000